Company
United StatesPublic company, NASDAQ: RCKTRocket Pharmaceuticals, Inc. (NASDAQ: RCKT), Cranbury, NJ – FDA Inspections
Inspection records and compliance data for Rocket Pharmaceuticals, Inc. in Cranbury, New Jersey. 1 FDA inspection on record, last inspected January 25, 2024. Publicly traded as NASDAQ: RCKT.
Company Profile
This profile covers Rocket Pharmaceuticals, Inc. based in Cranbury, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected January 25, 2024.
Most cited issue areas
- General responsibilities of sponsors1 inspection
- Investigator statement (FDA 1572)1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 25, 2024 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1227760 |
FDA documents
Form 483s (1)
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Rocket Pharmaceuticals, Inc.
Stock ticker
RCKT
Exchange
NASDAQ
Share price
$2.39
Market cap
$266.9M
Price as of
November 13, 2026
FEI Number
3017199602
Address
9 Cedarbrook Dr, Cranbury, New Jersey 08512, United States
Country
United States
ID: a12f4053-7714-4002-87e2-94432dd3f3ed